Cholesterol-lowering drugs may help prevent recurrent strokes in younger people

New research indicates cholesterol lowering drugs known as statins may help prevent future strokes among young people who have already had a stroke. The study is published in the August 2, 2011, print issue of Neurology, the medical journal of the American Academy of Neurology.

"Because the cause of stroke in young people can be hard to identify, are often not used to prevent further strokes or vascular problems," said study author Jukka Putaala, MD, PhD, with the Helsinki University Central Hospital in Helsinki, Finland. "This study suggests that the drugs should be considered even when the cause of the stroke is unknown and the are not high."

For the study, researchers looked at the medical records of 215 people between the ages of 15 and 49 who experienced a first stroke called an and were then followed for an average of nine years.

One-third of the participants had taken a statin at some point after their stroke. Of the 36 people who continuously took a statin, no one had a second stroke or other vascular problem. Of the 36 people who took a statin at some point after their stroke, four people, or 11 percent, had a second stroke or other vascular problem. Of the 143 people who never took a statin drug, 29 people, or 20 percent, had a second stroke or other vascular problem.

The study found that those who were treated with a statin at any time after the stroke were 77 percent less likely to experience another stroke or vascular problems compared to those not treated with a statin at all. The results were the same after adjusting for factors such as age, , and taking high .

"While the study may be limited by the small number of people who were treated with a statin, at the very least, who have experienced a stroke for unknown reasons should be considered for treatment with cholesterol-lowering drugs," said Putaala.

add to favorites email to friend print save as pdf

Related Stories

Cholesterol-lowering drugs and the risk of hemorrhagic stroke

Dec 12, 2007

People taking cholesterol-lowering drugs such as atorvastatin after a stroke may be at an increased risk of hemorrhagic stroke, or bleeding in the brain, a risk not found in patients taking statins who have never had a stroke. ...

Statins lower stroke severity, improve recovery

Feb 26, 2009

Mayo Clinic researchers have shown that patients who were taking statins before a stroke experienced better outcomes and recovery than patients who weren't on the drug — even when their cholesterol levels were ideal. The ...

Recommended for you

Meningococcal disease ID'd in men who have sex with men

14 hours ago

(HealthDay)—Following reports of invasive meningococcal disease (IMD) among men who have sex with men (MSM), the New York City (NYC) Department of Health and Mental Hygiene (DOHMH) has recommended that ...

Measles epidemic sweeps northern Syria

17 hours ago

An epidemic of measles is sweeping through parts of northern Syria, with at least 7,000 people affected because the ongoing civil war has disrupted vaccination programmes, Doctors Without Borders said on Tuesday.

Whooping cough has lifelong health impact, study finds

18 hours ago

People born during whooping cough outbreaks are more likely to die prematurely even if they survive into adulthood, research at Lund University in Sweden has found. Women had a 20% higher risk of an early death, and men a ...

User comments

More news stories

Study suggests new approach to fight lung cancer

Recent research has shown that cancer cells have a much different – and more complex – metabolism than normal cells. Now, scientists at The University of Texas at Dallas have found that exploiting these differences might ...

Getting enough sleep could help prevent type 2 diabetes

Men who lose sleep during the work week may be able to lower their risk of developing Type 2 diabetes by getting more hours of sleep, according to Los Angeles Biomedical Research Institute (LA BioMed) research findings presented ...

Aspirin may fight cancer by slowing DNA damage

Aspirin is known to lower risk for some cancers, and a new study led by a UC San Francisco scientist points to a possible explanation, with the discovery that aspirin slows the accumulation of DNA mutations in abnormal cells ...